Abstract
The 2004 PT Section Education Committee took the first steps in addressing the charge: “How can the supply of highly qualified pharmaceutical scientist specialists in product development and related technologies that meet current and future needs be ensured?” This charge was borne out of earlier reports and current experience that suggest that: (1) graduate programs in colleges of pharmacy are increasingly failing to produce sufficient numbers of appropriately qualified specialists in product development and related pharmaceutical technologies and, (2) the pharmaceutical industry has been forced to recruit and train scientists from other disciplines. Surveys conducted by this committee of the membership (PT, PDD and BT sections) and a representative group of pharmaceutical executives validated this concern and provided insight into its nature and depth. For example, the executives reported that 50% or less of product development staff have undergraduate degrees in pharmacy and that 50% or less have advanced degrees in pharmaceutics/industrial pharmacy/pharmaceutical technology, yet entry-level PhDs in these specialties bring a better mix of skills to the product development table than their counterparts from other science disciplines, and that this advantage persist even after 4–6 years experience on the job. And the great difficulty in finding candidates with the, right mix of experience and education was also made clear by the surveys. Based in part on an analysis of these surveys, this committee developed an extensive list of issues to be addressed by future PT Education committees and AAPS. Among these were: (1) Should AAPS encourage and assist in the establishment of graduate programs in product development/technology and/or tracks in academic institutions whether or not they are colleges of pharmacy?, (2) Should AAPS develop standards for and qualify such educational programs and tracks? (3) How do we and what role should AAPS play in creating awareness in colleges and universities of our needs and the incentives to develop and maintain programs that meet these needs?, and (4) How can stable funding be provided for programs in product development and technology?